Black Diamond Therapeutics, Inc. (BDTX) vs Cyteir Therapeutics, Inc. (CYTT)

Black Diamond Therapeutics, Inc. and Cyteir Therapeutics, Inc. are both Biotechnology companies. Black Diamond Therapeutics, Inc. and Cyteir Therapeutics, Inc. are of similar size ($108.7M and $108.6M). Across the 9 metrics below, Cyteir Therapeutics, Inc. leads on 6 and Black Diamond Therapeutics, Inc. on 3.

Valuation

Metric BDTX CYTT Biotechnology median
P/E n/m n/m 7.88
P/S n/m n/m 11.47
P/B 1.13 0.87 2.52
Price to free cash flow n/m n/m 21.16
EV/EBITDA 0.04 0.55 0.74
EV/Sales n/m n/m 10.73
Earnings yield (39.68%) (31.23%) (28.84%)
Free cash flow yield (30.26%) (23.50%) (23.03%)

Profitability

Metric BDTX CYTT Biotechnology median
Gross margin 0.00% 0.00% 65.16%
Operating margin 0.00% 0.00% 0.00%
Net margin 0.00% 0.00% 0.00%
Free cash flow margin 0.00% 0.00% 0.00%
Return on equity (37.21%) (23.80%) (57.72%)
Return on assets (29.21%) (22.70%) (49.22%)
Return on invested capital 0.00% 0.00% 0.00%

Growth

Metric BDTX CYTT Biotechnology median
Revenue growth (TTM) — — 5.64%
EPS growth (last fiscal year) 130.71% 39.35% —
Revenue growth, 5-year CAGR — — 8.40%
Net income growth, 5-year CAGR 0.00% — 0.00%

Health

Metric BDTX CYTT Biotechnology median
Debt to equity 0.00 0.00 0.00
Current ratio 7.28 21.89 4.73
Net debt to EBITDA (10.01) 3.10 0.96

Dividend

Metric BDTX CYTT Biotechnology median
Dividend yield — — 2.10%
Payout ratio 0.00 0.00 0.00

Size

Metric BDTX CYTT Biotechnology median
Market cap 108.59m 108.72m 162.10m

Compare with another peer

Any metric, up to five companies and an Excel export Powerpack